Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs).

MLA

Chen, Maosheng, et al. “Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (PDCs).” Stem Cells International, Nov. 2019, pp. 1–13. EBSCOhost, https://doi.org/10.1155/2019/6961052.

APA

Chen, M., Peng, J., Xie, Q., Xiao, N., Su, X., Mei, H., Lu, Y., Zhou, J., Dai, Y., Wang, S., Li, C., Lin, G., & Cheng, L. (2019). Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (pDCs). Stem Cells International, 1–13. https://doi.org/10.1155/2019/6961052

Chicago

Chen, Maosheng, Jing Peng, Qi Xie, Na Xiao, Xian Su, Hua Mei, Yeping Lu, et al. 2019. “Mesenchymal Stem Cells Alleviate Moderate-to-Severe Psoriasis by Reducing the Production of Type I Interferon (IFN-I) by Plasmacytoid Dendritic Cells (PDCs).” Stem Cells International, November, 1–13. doi:10.1155/2019/6961052.